Lapucci and colleagues investigated the effect of the Class II HDAC inhibitor MC1568 on expression of EAAT2, glutamate uptake, and survival of SOD1G93A ALS mice [240]. The gene discussed is HDAC9; the disease is amyotrophic lateral sclerosis.